LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

The vast majority of positive tests have come from people in Bangor who have either been homeless, injection drug users, or ...

A federal judge on Thursday extended a temporary legal block that prevents Idaho from verifying the immigration status of ...

HIV funding cuts. 820 words. 2 photos available. PHOENIX – Ending the spread of HIV in Arizona may become more difficult if ...